Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing how Evolv Technologies turns cloud subscriptions and advanced sensors into sustained cash flow isn’t easy—its annual report alone tops 300 pages. If you have ever searched for “Evolv Technologies SEC filings explained simply” or wondered where deferred revenue is hiding, you know the challenge. Stock Titan’s AI reads every line the moment it hits EDGAR and converts dense accounting language into clear insights you can act on.
Tap into real-time coverage of every document type. Our platform links “Evolv Technologies quarterly earnings report 10-Q filing” to concise margin breakdowns, tags each “Evolv Technologies 8-K material events explained”, and delivers alerts for “Evolv Technologies Form 4 insider transactions real-time”. Need context fast? AI-powered summaries highlight how sensor R&D affects gross profit, while side-by-side views let you compare periods without scrolling through PDF footnotes.
Whether you’re tracking “Evolv Technologies insider trading Form 4 transactions” before a contract win, dissecting backlog trends in the “Evolv Technologies annual report 10-K simplified”, or checking the “Evolv Technologies proxy statement executive compensation” for alignment with growth, Stock Titan keeps critical data at your fingertips. Practical benefits include:
- AI summaries that make “understanding Evolv Technologies SEC documents with AI” effortless
- Drill-downs into “Evolv Technologies earnings report filing analysis” across segments
- One-click export of “Evolv Technologies executive stock transactions Form 4” for modelling
No more manual downloads or missed filings—our system refreshes the moment Evolv uploads, so you stay ahead of every disclosure that moves the stock.
Michael Ellenbogen, Founder & Chief Innovation Officer and Director of Evolv Technologies Holdings, reported significant changes in beneficial ownership on June 23, 2025. The key transaction involved the transfer of investment control of 2,259,987 shares of Class A Common Stock previously held by E Ventures Trust to an independent investment advisor.
Following this transaction, Ellenbogen's holdings include:
- 2,083,961 shares held directly
- 151,135 shares held indirectly through Family Horizon Trust
The transfer of investment control means Ellenbogen no longer has beneficial ownership of the E Ventures Trust shares and will not include them in future Section 16 reports. This represents a significant change in his control over company shares while maintaining his executive and board positions.
Director Mark J. Sullivan of Evolv Technologies Holdings (EVLV) received a grant of 27,050 Restricted Stock Units (RSUs) on June 20, 2025. Each RSU represents the right to receive one share of Class A common stock.
Key terms of the RSU grant:
- The RSUs will fully vest on the earlier of June 20, 2026 or the day before the next annual meeting
- The RSUs were granted at no cost ($0)
- The securities are held in direct ownership
- The RSUs have no expiration date
This Form 4 filing was submitted by Rachel Roy as attorney-in-fact for Mark Sullivan on June 24, 2025, within the required reporting window for insider transactions.
Evolv Technologies Holdings (EVLV) reported a Form 4 filing disclosing an insider transaction by Director David Mounts Gonzales on June 20, 2025. The director was granted 27,050 Restricted Stock Units (RSUs) as part of the company's equity compensation plan.
Key details of the RSU grant:
- Each RSU represents a right to receive one share of Class A common stock
- The RSUs were granted at $0 cost to the director
- Vesting will occur in full at the earlier of June 20, 2026 or the day before the next annual meeting
- The RSUs have no expiration date
This transaction appears to be part of standard director compensation arrangements. The filing was signed by Rachel Roy as attorney-in-fact for David Mounts Gonzales on June 24, 2025.